These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7772678)

  • 21. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
    Black MJ; Campbell JH; Campbell GR
    Am J Cardiol; 1993 Jun; 71(17):17E-21E. PubMed ID: 8328362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition.
    Thuillez C; Mulder P; Elfertak L; Blaysat G; Compagnon P; Henry JP; Richard V; Scalbert E; Desche P
    Am J Hypertens; 1995 May; 8(5 Pt 2):7S-12S. PubMed ID: 7646844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.
    Rolland PH; Charpiot P; Friggi A; Piquet P; Barlatier A; Scalbert E; Bodard H; Tranier P; Mercier C; Luccioni R
    Am J Cardiol; 1993 Jun; 71(17):22E-27E. PubMed ID: 8328363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes.
    Soulis T; Sastra S; Thallas V; Mortensen SB; Wilken M; Clausen JT; Bjerrum OJ; Petersen H; Lau J; Jerums G; Boel E; Cooper ME
    Diabetologia; 1999 Apr; 42(4):472-9. PubMed ID: 10230652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
    Candido R; Jandeleit-Dahm KA; Cao Z; Nesteroff SP; Burns WC; Twigg SM; Dilley RJ; Cooper ME; Allen TJ
    Circulation; 2002 Jul; 106(2):246-53. PubMed ID: 12105166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
    Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
    Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
    Cousin M; Custaud MA; Baron-Menguy C; Toutain B; Dumont O; Guihot AL; Vessières E; Subra JF; Henrion D; Loufrani L
    Hypertension; 2010 Jan; 55(1):109-15. PubMed ID: 19948989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
    Cooper ME; Rumble JR; Gin T; Lim-Joon T
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.
    Jandeleit-Dahm K; Rumble J; Cox AJ; Kelly DJ; Dziadek M; Cooper ME; Gilbert RE
    Microvasc Res; 2000 Jan; 59(1):61-71. PubMed ID: 10625572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC; Cooper ME; Jerums G; Doyle AE
    Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
    Allen TJ; Hulthen UL; Rumble JR; Jasik M; Cooper ME
    J Diabetes Complications; 1995; 9(4):318-22. PubMed ID: 8573756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure?
    Christensen HR; Nielsen H; Christensen KL; Baandrup U; Jespersen LT; Mulvany MJ
    J Hypertens Suppl; 1988 Dec; 6(3):S27-31. PubMed ID: 3225687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus.
    Jandeleit K; Rumble J; Jackson B; Cooper ME
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):343-7. PubMed ID: 1325883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction.
    Yoshida K; Kohzuki M; Casley DJ; Johnston CI
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):357-65. PubMed ID: 9733347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of perindopril on vascular wall and left ventricular hypertrophy in rats with experimental hypertension.
    Tang J; Zhou Q; Wu C; Liang Q
    J Tongji Med Univ; 1998; 18(2):78-82. PubMed ID: 10806829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus.
    McFarlane R; McCredie RJ; Bonney MA; Molyneaux L; Zilkens R; Celermajer DS; Yue DK
    Diabet Med; 1999 Jan; 16(1):62-6. PubMed ID: 10229295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes.
    Gilbert RE; Rumble JR; Cao Z; Cox AJ; van Eeden P; Allen TJ; Kelly DJ; Cooper ME
    Circ Res; 2000 Feb; 86(2):158-65. PubMed ID: 10666411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.